Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo.
暂无分享,去创建一个
Sergey Kasparov | Julian F R Paton | J. Paton | S. Kasparov | M. Huentelman | S. Semple-Rowland | M. Raizada | M. Katovich | J. E. Coleman | Matthew J Huentelman | Mohan K Raizada | Jason E Coleman | Beverly L Metcalfe | Michael J Katovich | Susan L Semple-Rowland | B. L. Metcalfe
[1] I. Verma,et al. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[2] M. Ohkawa,et al. Neonatally administered diethylstilbestrol retards the development of the blood-testis barrier in the rat. , 2001, Journal of andrology.
[3] Y. Ron,et al. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. , 2001, Virology.
[4] Fred H. Gage,et al. Development of a Self-Inactivating Lentivirus Vector , 1998, Journal of Virology.
[5] J. Biegel,et al. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] L. Ailles,et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.
[7] M. Kumar,et al. Systematic determination of the packaging limit of lentiviral vectors. , 2001, Human gene therapy.
[8] T. Iwakuma,et al. Self-inactivating lentiviral vectors with U3 and U5 modifications. , 1999, Virology.
[9] T. Iwakuma,et al. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system , 1999, Gene Therapy.
[10] S. Semple-Rowland,et al. Analyses of the guanylate cyclase activating protein-1 gene promoter in the developing retina. , 2002, Investigative ophthalmology & visual science.
[11] D. Trono,et al. Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.
[12] Philippe Colin,et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain , 2001, Nature Biotechnology.
[13] D. Trono,et al. A stable system for the high-titer production of multiply attenuated lentiviral vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[14] Luc Montagnier,et al. HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.
[15] A. Consiglio,et al. A new-generation stable inducible packaging cell line for lentiviral vectors. , 2001, Human gene therapy.
[16] M. Huentelman,et al. Large-scale production of retroviral vectors for systemic gene delivery. , 2002, Methods in enzymology.
[17] G. Ramı́rez,et al. Spatial and Temporal Patterns of Neurogenesis in the Chick Retina. , 1991, The European journal of neuroscience.
[18] C. Tabin,et al. Production and design of more effective avian replication-incompetent retroviral vectors. , 1999, Developmental biology.
[19] Lung-Ji Chang,et al. RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy , 2002, Journal of Virology.
[20] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[21] T. Iwakuma,et al. Contributions of Viral Splice Sites andcis-Regulatory Elements to Lentivirus Vector Function , 1999, Journal of Virology.
[22] D. Kristoffersen,et al. Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media. , 1992, European journal of radiology.
[23] C. Cepko,et al. Replication-competent retroviral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo , 1993, Molecular and cellular biology.
[24] R. Braun,et al. Absence of germline infection in male mice following intraventricular injection of adenovirus. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.